Chris Wealth Management

Search This Blog

Anthem Biosciences IPO subscribed 2x on day 2; Check GMP, and other key details

Posted by Able on July 15, 2025

Get link
Facebook
X
Pinterest
Email
Other Apps

Anthem Biosciences IPO subscribed 2.08x by Day 2, 1:15 p.m.

Strong NII interest with 5.75x subscription; retail at 1.78x.

QIBs subscribed 44% of their allotted quota.

Grey market premium at Rs 116–121 signals ~20% listing gain.

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Stock Market LIVE Updates: Hong Kong stocks notch 9-day winning streak in longest rally since 2018

Hong Kong stocks extended their rally on Friday, supported by ongoing positive market sentiment fueled by China's increased economic stimulus measures. The Hang Seng Index surged by 1.5%, marking its ninth consecutive day of gains, the longest winning streak since January 2018. Hong Kong-listed Chinese tech giants also saw continued gains, closing 2.7% higher.

Jiraaf launches India’s first Bond Analyser to decode fixed-income investing

Jiraaf launches Bond Analyser to simplify bond investing for retail investors. Tool compares yields by rating, tenure, and issuer using public data. Aims to close the research gap in India’s growing fixed-income market. Future updates may include scenario modeling and structured debt analysis.

GST Reforms 2.0: Full list of over 40 stocks that can benefit from PM Modi's Diwali promise

Prime Minister Narendra Modi's bombshell Independence Day announcement to overhaul India's GST structure by Diwali has sent shockwaves through Dalal Street, with over 40 stocks across sectors from autos to cement now firmly in brokerages' crosshairs as potential big winners. The market's euphoric response on Monday saw massive rallies across auto, financial, real estate, consumer, and cement stocks as investors scrambled to position themselves ahead of what analysts are calling the most significant indirect tax reform since GST's 2017 launch.

Anthem Biosciences IPO subscribed 2x on day 2; Check GMP, and other key details

Comments

Post a Comment